These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35382109)

  • 21. Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar
    Askanase AD; Wan GJ; Panaccio MP; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2021 Mar; 8(1):573-584. PubMed ID: 33687687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records.
    Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ
    Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repository corticotropin injection in patients with refractory psoriatic arthritis: a case series.
    Brown AN
    Open Access Rheumatol; 2016; 8():97-102. PubMed ID: 27956846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
    Wynn D; Goldstick L; Bauer W; Zhao E; Tarau E; Cohen JA; Robertson D; Miller A
    CNS Neurosci Ther; 2022 Mar; 28(3):364-371. PubMed ID: 34984839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial.
    Askanase AD; Zhao E; Zhu J; Connolly-Strong E; Furie RA
    Lupus Sci Med; 2020; 7(1):e000383. PubMed ID: 32399253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms.
    Duchowny MS; Chopra I; Niewoehner J; Wan GJ; Devine B
    J Health Econ Outcomes Res; 2021 Jan; 8(1):1-9. PubMed ID: 33521161
    [No Abstract]   [Full Text] [Related]  

  • 27. Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus.
    Askanase AD; Wright D; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2021 Dec; 8(4):1871-1886. PubMed ID: 34478124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies.
    Fischer PA; Rapoport RJ
    Open Access Rheumatol; 2018; 10():13-19. PubMed ID: 29445306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
    Mirsaeidi M; Baughman RP
    Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repository Corticotropin Injection (Acthar
    Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
    Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.
    Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ
    J Health Econ Outcomes Res; 2022; 9(1):90-100. PubMed ID: 35529249
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective Medical Record Review to Describe Use of Repository Corticotropin Injection Among Patients with Uveitis in the United States.
    Nelson WW; Lima AF; Kranyak J; Opong-Owusu B; Ciepielewska G; Gallagher JR; Heap K; Carroll S
    J Ocul Pharmacol Ther; 2019 Apr; 35(3):182-188. PubMed ID: 30676837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up results of myositis patients treated with H. P. Acthar gel.
    Saygin D; Oddis CV; Marder G; Moghadam-Kia S; Nandkumar P; Neiman N; Dzanko S; Koontz D; Aggarwal R
    Rheumatology (Oxford); 2020 Oct; 59(10):2976-2981. PubMed ID: 32160301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort.
    Tillett W; Birt J; Cavanaugh C; Jung Y; Vadhariya A; Ross S; Paulus J; Lubrano E
    Front Med (Lausanne); 2023; 10():1184028. PubMed ID: 37415769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms.
    Gold LS; Nazareth TA; Yu TC; Fry KR; Mahler NH; Rava A; Waltrip Ii RW; Hansen RN
    Pediatric Health Med Ther; 2019; 10():195-207. PubMed ID: 32099512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial.
    van der Leeuw MS; Welsing PMJ; de Hair MJH; Jacobs JWG; Marijnissen ACA; Linn-Rasker SP; Fodili F; Bos R; Tekstra J; van Laar JM
    Trials; 2020 Apr; 21(1):313. PubMed ID: 32248829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Repository Corticotropin Injection on Medication Use in Patients With Rheumatologic Conditions: A Claims Data Study.
    Myung G; Nelson WW; McMahon MA
    J Pharm Technol; 2017 Aug; 33(4):151-155. PubMed ID: 34861677
    [No Abstract]   [Full Text] [Related]  

  • 39. A Narrative Review of Acthar Gel for the Treatment of Myositis.
    Chandra T; Aggarwal R
    Rheumatol Ther; 2023 Jun; 10(3):523-537. PubMed ID: 36966453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA.
    Bell CF; Huang SP; Yu LH; DerSarkissian M; Germain G; Concoff AL; Averell CM; Rubin B; Gu YM; Duh MS; Wallace DJ
    Rheumatol Ther; 2023 Feb; 10(1):261-274. PubMed ID: 36471198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.